Pharma & Healthcare

Global Respiratory Disease Vaccine Market Research Report 2026

This report delivers a comprehensive overview of the global Respiratory Disease Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Respiratory Disease Vaccine. The Respiratory Disease Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Respiratory Disease Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Respiratory Disease Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
AstraZeneca
Emergent BioSolutions Inc.
GSK plc.
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Novavax
Pfizer Inc.
Sanofi SA
Serum Institute of India Pvt. Ltd.
SINOVAC
Segment by Type
Live Attenuated
Inactivated
Others
by Application
Flu
Pneumonia
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Respiratory Disease Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Respiratory Disease Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Respiratory Disease Vaccine Market Overview
1.1 Product Definition
1.2 Respiratory Disease Vaccine by Type
1.2.1 Global Respiratory Disease Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Live Attenuated
1.2.3 Inactivated
1.2.4 Others
1.3 Respiratory Disease Vaccine by Application
1.3.1 Global Respiratory Disease Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Flu
1.3.3 Pneumonia
1.3.4 Others
1.4 Global Respiratory Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Respiratory Disease Vaccine Revenue 2021–2032
1.4.2 Global Respiratory Disease Vaccine Sales 2021–2032
1.4.3 Global Respiratory Disease Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Respiratory Disease Vaccine Market Competition by Manufacturers
2.1 Global Respiratory Disease Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Respiratory Disease Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Respiratory Disease Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Respiratory Disease Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Respiratory Disease Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Respiratory Disease Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Respiratory Disease Vaccine, Date of Entry into the Industry
2.8 Global Respiratory Disease Vaccine Market Competitive Situation and Trends
2.8.1 Global Respiratory Disease Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Respiratory Disease Vaccine Players Market Share by Revenue
2.8.3 Global Respiratory Disease Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Respiratory Disease Vaccine Market Scenario by Region
3.1 Global Respiratory Disease Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Respiratory Disease Vaccine Sales by Region: 2021–2032
3.2.1 Global Respiratory Disease Vaccine Sales by Region: 2021–2026
3.2.2 Global Respiratory Disease Vaccine Sales by Region: 2027–2032
3.3 Global Respiratory Disease Vaccine Revenue by Region: 2021–2032
3.3.1 Global Respiratory Disease Vaccine Revenue by Region: 2021–2026
3.3.2 Global Respiratory Disease Vaccine Revenue by Region: 2027–2032
3.4 North America Respiratory Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Respiratory Disease Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Respiratory Disease Vaccine Sales by Country (2021–2032)
3.4.3 North America Respiratory Disease Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Respiratory Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Respiratory Disease Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Respiratory Disease Vaccine Sales by Country (2021–2032)
3.5.3 Europe Respiratory Disease Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Respiratory Disease Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Respiratory Disease Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Respiratory Disease Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Respiratory Disease Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Respiratory Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Respiratory Disease Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Respiratory Disease Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Respiratory Disease Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Respiratory Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Respiratory Disease Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Respiratory Disease Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Respiratory Disease Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Respiratory Disease Vaccine Sales by Type (2021–2032)
4.1.1 Global Respiratory Disease Vaccine Sales by Type (2021–2026)
4.1.2 Global Respiratory Disease Vaccine Sales by Type (2027–2032)
4.1.3 Global Respiratory Disease Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Respiratory Disease Vaccine Revenue by Type (2021–2032)
4.2.1 Global Respiratory Disease Vaccine Revenue by Type (2021–2026)
4.2.2 Global Respiratory Disease Vaccine Revenue by Type (2027–2032)
4.2.3 Global Respiratory Disease Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Respiratory Disease Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Respiratory Disease Vaccine Sales by Application (2021–2032)
5.1.1 Global Respiratory Disease Vaccine Sales by Application (2021–2026)
5.1.2 Global Respiratory Disease Vaccine Sales by Application (2027–2032)
5.1.3 Global Respiratory Disease Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Respiratory Disease Vaccine Revenue by Application (2021–2032)
5.2.1 Global Respiratory Disease Vaccine Revenue by Application (2021–2026)
5.2.2 Global Respiratory Disease Vaccine Revenue by Application (2027–2032)
5.2.3 Global Respiratory Disease Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Respiratory Disease Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Respiratory Disease Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AstraZeneca Respiratory Disease Vaccine Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Emergent BioSolutions Inc.
6.2.1 Emergent BioSolutions Inc. Company Information
6.2.2 Emergent BioSolutions Inc. Description and Business Overview
6.2.3 Emergent BioSolutions Inc. Respiratory Disease Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Emergent BioSolutions Inc. Respiratory Disease Vaccine Product Portfolio
6.2.5 Emergent BioSolutions Inc. Recent Developments/Updates
6.3 GSK plc.
6.3.1 GSK plc. Company Information
6.3.2 GSK plc. Description and Business Overview
6.3.3 GSK plc. Respiratory Disease Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 GSK plc. Respiratory Disease Vaccine Product Portfolio
6.3.5 GSK plc. Recent Developments/Updates
6.4 Johnson & Johnson Services, Inc.
6.4.1 Johnson & Johnson Services, Inc. Company Information
6.4.2 Johnson & Johnson Services, Inc. Description and Business Overview
6.4.3 Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Product Portfolio
6.4.5 Johnson & Johnson Services, Inc. Recent Developments/Updates
6.5 Merck & Co., Inc.
6.5.1 Merck & Co., Inc. Company Information
6.5.2 Merck & Co., Inc. Description and Business Overview
6.5.3 Merck & Co., Inc. Respiratory Disease Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Merck & Co., Inc. Respiratory Disease Vaccine Product Portfolio
6.5.5 Merck & Co., Inc. Recent Developments/Updates
6.6 Novavax
6.6.1 Novavax Company Information
6.6.2 Novavax Description and Business Overview
6.6.3 Novavax Respiratory Disease Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Novavax Respiratory Disease Vaccine Product Portfolio
6.6.5 Novavax Recent Developments/Updates
6.7 Pfizer Inc.
6.7.1 Pfizer Inc. Company Information
6.7.2 Pfizer Inc. Description and Business Overview
6.7.3 Pfizer Inc. Respiratory Disease Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Pfizer Inc. Respiratory Disease Vaccine Product Portfolio
6.7.5 Pfizer Inc. Recent Developments/Updates
6.8 Sanofi SA
6.8.1 Sanofi SA Company Information
6.8.2 Sanofi SA Description and Business Overview
6.8.3 Sanofi SA Respiratory Disease Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sanofi SA Respiratory Disease Vaccine Product Portfolio
6.8.5 Sanofi SA Recent Developments/Updates
6.9 Serum Institute of India Pvt. Ltd.
6.9.1 Serum Institute of India Pvt. Ltd. Company Information
6.9.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.9.3 Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Product Portfolio
6.9.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.10 SINOVAC
6.10.1 SINOVAC Company Information
6.10.2 SINOVAC Description and Business Overview
6.10.3 SINOVAC Respiratory Disease Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 SINOVAC Respiratory Disease Vaccine Product Portfolio
6.10.5 SINOVAC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Respiratory Disease Vaccine Industry Chain Analysis
7.2 Respiratory Disease Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Respiratory Disease Vaccine Production Mode & Process Analysis
7.4 Respiratory Disease Vaccine Sales and Marketing
7.4.1 Respiratory Disease Vaccine Sales Channels
7.4.2 Respiratory Disease Vaccine Distributors
7.5 Respiratory Disease Vaccine Customer Analysis
8 Respiratory Disease Vaccine Market Dynamics
8.1 Respiratory Disease Vaccine Industry Trends
8.2 Respiratory Disease Vaccine Market Drivers
8.3 Respiratory Disease Vaccine Market Challenges
8.4 Respiratory Disease Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Respiratory Disease Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Respiratory Disease Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Respiratory Disease Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Respiratory Disease Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Respiratory Disease Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Respiratory Disease Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Respiratory Disease Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Respiratory Disease Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Respiratory Disease Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Respiratory Disease Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Respiratory Disease Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Respiratory Disease Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Respiratory Disease Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Respiratory Disease Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Respiratory Disease Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Respiratory Disease Vaccine Sales by Region (K Units), 2021–2026
Table 18. Global Respiratory Disease Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Respiratory Disease Vaccine Sales by Region (K Units), 2027–2032
Table 20. Global Respiratory Disease Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Respiratory Disease Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Respiratory Disease Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Respiratory Disease Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Respiratory Disease Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Respiratory Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Respiratory Disease Vaccine Sales by Country (K Units), 2021–2026
Table 27. North America Respiratory Disease Vaccine Sales by Country (K Units), 2027–2032
Table 28. North America Respiratory Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Respiratory Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Respiratory Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Respiratory Disease Vaccine Sales by Country (K Units), 2021–2026
Table 32. Europe Respiratory Disease Vaccine Sales by Country (K Units), 2027–2032
Table 33. Europe Respiratory Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Respiratory Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Respiratory Disease Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Respiratory Disease Vaccine Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Respiratory Disease Vaccine Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Respiratory Disease Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Respiratory Disease Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Respiratory Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Respiratory Disease Vaccine Sales by Country (K Units), 2021–2026
Table 42. Latin America Respiratory Disease Vaccine Sales by Country (K Units), 2027–2032
Table 43. Latin America Respiratory Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Respiratory Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Respiratory Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Respiratory Disease Vaccine Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Respiratory Disease Vaccine Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Respiratory Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Respiratory Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Respiratory Disease Vaccine Sales (K Units) by Type (2021–2026)
Table 51. Global Respiratory Disease Vaccine Sales (K Units) by Type (2027–2032)
Table 52. Global Respiratory Disease Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Respiratory Disease Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Respiratory Disease Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Respiratory Disease Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Respiratory Disease Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Respiratory Disease Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Respiratory Disease Vaccine Price (US$/Unit) by Type (2021–2026)
Table 59. Global Respiratory Disease Vaccine Price (US$/Unit) by Type (2027–2032)
Table 60. Global Respiratory Disease Vaccine Sales (K Units) by Application (2021–2026)
Table 61. Global Respiratory Disease Vaccine Sales (K Units) by Application (2027–2032)
Table 62. Global Respiratory Disease Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Respiratory Disease Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Respiratory Disease Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Respiratory Disease Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Respiratory Disease Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Respiratory Disease Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Respiratory Disease Vaccine Price (US$/Unit) by Application (2021–2026)
Table 69. Global Respiratory Disease Vaccine Price (US$/Unit) by Application (2027–2032)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. AstraZeneca Respiratory Disease Vaccine Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Emergent BioSolutions Inc. Company Information
Table 76. Emergent BioSolutions Inc. Description and Business Overview
Table 77. Emergent BioSolutions Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Emergent BioSolutions Inc. Respiratory Disease Vaccine Product
Table 79. Emergent BioSolutions Inc. Recent Developments/Updates
Table 80. GSK plc. Company Information
Table 81. GSK plc. Description and Business Overview
Table 82. GSK plc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. GSK plc. Respiratory Disease Vaccine Product
Table 84. GSK plc. Recent Developments/Updates
Table 85. Johnson & Johnson Services, Inc. Company Information
Table 86. Johnson & Johnson Services, Inc. Description and Business Overview
Table 87. Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Product
Table 89. Johnson & Johnson Services, Inc. Recent Developments/Updates
Table 90. Merck & Co., Inc. Company Information
Table 91. Merck & Co., Inc. Description and Business Overview
Table 92. Merck & Co., Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Merck & Co., Inc. Respiratory Disease Vaccine Product
Table 94. Merck & Co., Inc. Recent Developments/Updates
Table 95. Novavax Company Information
Table 96. Novavax Description and Business Overview
Table 97. Novavax Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Novavax Respiratory Disease Vaccine Product
Table 99. Novavax Recent Developments/Updates
Table 100. Pfizer Inc. Company Information
Table 101. Pfizer Inc. Description and Business Overview
Table 102. Pfizer Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer Inc. Respiratory Disease Vaccine Product
Table 104. Pfizer Inc. Recent Developments/Updates
Table 105. Sanofi SA Company Information
Table 106. Sanofi SA Description and Business Overview
Table 107. Sanofi SA Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Sanofi SA Respiratory Disease Vaccine Product
Table 109. Sanofi SA Recent Developments/Updates
Table 110. Serum Institute of India Pvt. Ltd. Company Information
Table 111. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 112. Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Product
Table 114. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 115. SINOVAC Company Information
Table 116. SINOVAC Description and Business Overview
Table 117. SINOVAC Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. SINOVAC Respiratory Disease Vaccine Product
Table 119. SINOVAC Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Respiratory Disease Vaccine Distributors List
Table 123. Respiratory Disease Vaccine Customers List
Table 124. Respiratory Disease Vaccine Market Trends
Table 125. Respiratory Disease Vaccine Market Drivers
Table 126. Respiratory Disease Vaccine Market Challenges
Table 127. Respiratory Disease Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report


List of Figures
Figure 1. Product Picture of Respiratory Disease Vaccine
Figure 2. Global Respiratory Disease Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Respiratory Disease Vaccine Market Share by Type: 2025 & 2032
Figure 4. Live Attenuated Product Picture
Figure 5. Inactivated Product Picture
Figure 6. Others Product Picture
Figure 7. Global Respiratory Disease Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Respiratory Disease Vaccine Market Share by Application: 2025 & 2032
Figure 9. Flu
Figure 10. Pneumonia
Figure 11. Others
Figure 12. Global Respiratory Disease Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Respiratory Disease Vaccine Market Size (US$ Million), 2021–2032
Figure 14. Global Respiratory Disease Vaccine Sales (K Units), 2021–2032
Figure 15. Global Respiratory Disease Vaccine Average Price (US$/Unit), 2021–2032
Figure 16. Respiratory Disease Vaccine Report Years Considered
Figure 17. Respiratory Disease Vaccine Sales Share by Manufacturers in 2025
Figure 18. Global Respiratory Disease Vaccine Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Respiratory Disease Vaccine Players: Market Share by Revenue in Respiratory Disease Vaccine in 2025
Figure 20. Respiratory Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Respiratory Disease Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Respiratory Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 23. North America Respiratory Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 24. United States Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Respiratory Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 27. Europe Respiratory Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 28. Germany Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Respiratory Disease Vaccine Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Respiratory Disease Vaccine Revenue Market Share by Region (2021–2032)
Figure 35. China Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Respiratory Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 43. Latin America Respiratory Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Respiratory Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Respiratory Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Respiratory Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Respiratory Disease Vaccine by Type (2021–2032)
Figure 54. Global Revenue Market Share of Respiratory Disease Vaccine by Type (2021–2032)
Figure 55. Global Respiratory Disease Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Respiratory Disease Vaccine by Application (2021–2032)
Figure 57. Global Revenue Market Share of Respiratory Disease Vaccine by Application (2021–2032)
Figure 58. Global Respiratory Disease Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 59. Respiratory Disease Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies